Suppr超能文献

糖尿病技术与人为因素。

Diabetes technology and the human factor.

作者信息

Liberman A, Buckingham B, Phillip M

机构信息

Schneider Children's Medical Center of Israel, Petah Tikva, Israel.

出版信息

Int J Clin Pract Suppl. 2011 Feb(170):83-90. doi: 10.1111/j.1742-1241.2010.02583.x.

Abstract

When developing new technologies for human use the developer should take into consideration not only the efficacy and safety of the technology but also the desire and capabilities of the potential user. Any chronic disease is a challenge for both the patient and his/her caregivers. This statement is especially true in the case of patients with type 1 diabetes mellitus (T1DM) where adherence to therapy is crucial 24 hours a day 365 days a year. No vacation days are possible for the T1DM patient. It is therefore obvious why any new technology which is developed for helping patients cope with the disease should take into consideration the 'human factor' before, during and after the production process starts. There is no doubt that technology has changed the life of patients with T1DM in the last few decades, but despite the availability of new meters, new syringes, new sophisticated insulin pumps and continuous glucose sensors and communication tools, these technologies have not been well utilised by many patients. It is therefore important to understand why the technology is not always utilised and to find new ways to maximise use and benefits from the technology to as many patients as possible. The present chapter will review papers published in the last year where the patient's ability or willingness was an important factor in the success of the technology. We will try to understand why insulin pumps, glucose sensors and self-monitoring of blood glucose (SMBG) are not used enough or appropriately, whether there is a specific group that finds it more difficult than others to adopt new technologies and what can be done to overcome that issue. For this chapter we chose articles from a Public Medicine review of the literature related to human factors affecting the outcome of studies and of user acceptance of continuous glucose monitoring, insulin infusion pump therapy. We also searched the literature in the field of psychology in order to accurately define the problems that the users of technology are facing (such as adherence, quality of life, motivations, executive functioning etc.) Those articles that had the most important contributions to understanding human factors as well as those highlighting the interface between technology and psychology, were chosen for this review, with emphasis on articles that provide insight into future studies and acceptance of emerging technologies for glycemic control.

摘要

在开发供人类使用的新技术时,开发者不仅应考虑技术的有效性和安全性,还应考虑潜在用户的需求和能力。任何慢性病对患者及其护理人员来说都是一项挑战。对于1型糖尿病(T1DM)患者而言,这一说法尤为正确,因为他们一年365天、一天24小时都必须严格坚持治疗。T1DM患者没有休假的可能。因此显而易见,任何旨在帮助患者应对该疾病而开发的新技术,在生产过程开始之前、期间和之后都应考虑“人为因素”。毫无疑问,在过去几十年里,技术改变了T1DM患者的生活,但是尽管有了新的血糖仪、新的注射器、先进的胰岛素泵、持续葡萄糖监测仪以及通信工具,许多患者并未充分利用这些技术。因此,了解技术未被充分利用的原因并找到新方法,尽可能让更多患者最大限度地使用技术并从中受益,这一点很重要。本章将回顾去年发表的论文,其中患者的能力或意愿是技术成功的重要因素。我们将试图理解为什么胰岛素泵、葡萄糖传感器和自我血糖监测(SMBG)没有得到充分或恰当使用,是否存在比其他群体更难采用新技术的特定群体,以及如何解决这一问题。在本章中,我们从一份关于影响研究结果和用户对持续葡萄糖监测、胰岛素输注泵治疗接受度的人为因素的公共医学文献综述中选取了文章。我们还在心理学领域进行了文献检索,以便准确界定技术使用者所面临的问题(如依从性、生活质量、动机、执行功能等)。那些对理解人为因素有最重要贡献以及突出技术与心理学之间界面的文章被选入本综述,重点是那些能为未来研究以及新兴血糖控制技术的接受度提供见解的文章。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验